Company description

APM is the ticker symbol for Aptorum Group Limited, a global biopharmaceutical company focused on developing and commercializing innovative therapeutics and diagnostics to address unmet medical needs. The company was founded in 2017 and is headquartered in Hong Kong, with offices in New York, London, and Paris. APM utilizes advanced technologies such as artificial intelligence and microbiome research to enhance drug discovery and development processes. The company's pipeline includes treatments for a wide range of diseases and conditions, including infectious diseases, cancer, metabolic disorders, and neurological disorders. APM has also established partnerships and collaborations with leading academic institutions and research organizations to further enhance its research and development capabilities. With a dedicated team of experienced scientists and a strong commitment to improving global healthcare, APM is poised for continued growth and success in the biopharmaceutical industry.